After STZ use, a significant increase in escape latency (Figure 1A), travel length (Figure 1B), times cross the platform (Figure 1C), and a significant decrease in recognition index (Figure 1D) were found in mice with APP/PS1 transgenes and T2D as compared with mice that with APP/PS1 transgenes alone. Here, APP is linked to type 2 diabetes mellitus.